tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Pharmaxis Ltd Announces Substantial Shareholding Disclosure

Story Highlights
Pharmaxis Ltd Announces Substantial Shareholding Disclosure

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Pharmaxis Ltd ( (AU:SNT) ) has issued an update.

Pharmaxis Ltd has announced a substantial shareholding disclosure involving Syntara Limited and Platinum Investment Management Limited. This disclosure indicates a change in the interests of substantial holders, which could impact the company’s shareholder structure and influence its market dynamics.

More about Pharmaxis Ltd

YTD Price Performance: -5.00%

Average Trading Volume: 2,706,267

Technical Sentiment Signal: Sell

Current Market Cap: A$123.4M

For a thorough assessment of SNT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1